NASDAQ:MKD Molecular Data (MKD) Stock Price, News & Analysis → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free MKD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.40▼$0.7152-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Molecular Data alerts: Email Address Ad Behind the MarketsBlackRock Bets Big on Tiny BiotechAn undervalued biotech firm is on the verge of a major discovery - That has the potential to treat Alzheimer's, Parkinson's and Dementia. BlackRock is so confident in this firm, they've invested $298 million. Click here for the full story >>> About Molecular Data Stock (NASDAQ:MKD)Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People's Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry. The company offers its e-commerce solutions through online platform that consists of molbase.com and molbase.cn websites; Moku Data Weixin account; Chemical Community app; and other ancillary platforms. Molecular Data Inc. was founded in 2013 and is headquartered in Shanghai, the People's Republic of China.Read More Ad The Bull ReportThe AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.Click here to see who's preparing to meet these needs MKD Stock News HeadlinesMarch 16, 2024 | markets.businessinsider.comMolecular Partners AG: Strong Financials & Promising Pipeline Justify Buy RatingMarch 14, 2024 | msn.comStudy identifies molecular alterations in brain tissue and blood of people who committed suicideMarch 19, 2024 | The Bull Report (Ad)The AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.February 21, 2024 | msn.comNew findings on the link between myotonic dystrophy 2 and autoimmune diseasesFebruary 6, 2024 | msn.comStudy identifies molecular mechanisms of rare neurodevelopmental disorderFebruary 1, 2024 | msn.comHuman cells building 'molecular highways' captured for first timeJanuary 23, 2024 | msn.com4D Molecular gets FDA rare pediatric disease status for CF drugJanuary 14, 2024 | msn.comNew research provides a molecular look at the mechanisms behind pigmentation variationMarch 19, 2024 | Colonial Metals (Ad)Central Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.January 9, 2024 | msn.comResearch better characterizes a rare form of leukemia on the molecular levelJanuary 2, 2024 | msn.comPreviously unidentified protein variant shields against Parkinson's diseaseNovember 13, 2023 | tmcnet.comBostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual MeetingOctober 10, 2023 | markets.businessinsider.comCENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic OfferingAugust 15, 2023 | msn.comMolecular communication: Experts are interpreting the language of lifeAugust 9, 2023 | lse.co.ukMolecular Enrgy Share ChatJuly 28, 2023 | investing.comMolecular Data Inc (MKDTY)July 7, 2023 | msn.com4D Molecular Therapeutics: A Complicated StoryJune 19, 2023 | benzinga.comMolecular Diagnostics Partnering Deals Report 2016-2023 - Undertake Due Diligence to Assess Suitability of Your Proposed Deal TermsJune 7, 2023 | seekingalpha.com4D Molecular stock rallies following promising data for CF therapyMay 17, 2023 | marketwatch.comMolecular Biology Enzymes, Reagents And Kits Market Future Statistics and Probability by 2030May 17, 2023 | marketwatch.comMolecular Diagnostics and NAT Market Future Statistics and Probability by 2030May 11, 2023 | marketwatch.comMolecular Diagnostics (MDx) Point of Care Market Size Analysis Report 2023-2030 by Absolute Reports in Biotechnology Industry | with [98 Pages]May 11, 2023 | marketwatch.comMolecular Biology Analyzers Market Size and Projection from 2023 to 2030May 11, 2023 | marketwatch.comMolecular Biomarkers Market Research | 2023-2030May 9, 2023 | marketwatch.comMolecular Biology Kits Market Research | 2023-2030May 9, 2023 | marketwatch.comMolecular Diagnostics Systems Market Research, 2030May 6, 2023 | marketwatch.comMolecular Modelling Market [2023-2030] | Industry Booms GloballySee More Headlines Receive MKD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Molecular Data and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MKD CUSIPN/A CIK1758736 Webwww.molbase.cn Phone86-21-5436-5166Fax86-40-0602-1666Employees189Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Steven Foo (Age 50)CEO & CFO Dr. Dongliang Chang (Age 47)Founder & Chairman of Board of Directors Mr. Jingming ZhongCompliance OfficerKey CompetitorsEqonexNASDAQ:EQOSFull Truck AllianceNYSE:YMMIntegrated Media TechnologyNASDAQ:IMTEOnion GlobalNYSE:OGBLYPop Culture GroupNASDAQ:CPOPView All Competitors MKD Stock Analysis - Frequently Asked Questions When did Molecular Data's stock split? Molecular Data shares reverse split before market open on Monday, May 23rd 2022. The 1-15 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Molecular Data IPO? (MKD) raised $69 million in an initial public offering on the week of December 30th 2019. The company issued 11,500,000 shares at $5.00-$7.00 per share. AMTD, Fosun Hani and Boustead Securities served as the underwriters for the IPO and Tiger Brokers and Guotai Junan International were co-managers. This page (NASDAQ:MKD) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Data Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.